Atenolol 2care4 100 mg Filmdragerad tablett

Country: Շվեդիա

language: շվեդերեն

source: Läkemedelsverket (Medical Products Agency)

active_ingredient:

atenolol

MAH:

2care4 ApS

ATC_code:

C07AB03

INN:

atenolol

dosage:

100 mg

pharmaceutical_form:

Filmdragerad tablett

composition:

atenolol 100 mg Aktiv substans; propylenglykol Hjälpämne; natriumlaurilsulfat Hjälpämne

prescription_type:

Receptbelagt

leaflet_short:

Förpacknings: Blister, 100 tabletter

authorization_status:

Avregistrerad

authorization_date:

2019-04-24

PIL

1
PACKAGE LEAFLET: INFORMATION FOR THE USER
ATENOLOL ACTAVIS 25 MG FILM-COATED TABLETS
ATENOLOL ACTAVIS 50 MG FILM-COATED TABLETS
ATENOLOL ACTAVIS 100 MG FILM-COATED TABLETS
Atenolol
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What /…/ is and what it is used for
2.
What you need to know before you take /…/
3.
How to take /…/
4.
Possible side effects
5.
How to store /…/
6.
Contents of the pack and other information
1.
WHAT /…/ IS AND WHAT IT IS USED FOR
/…/ contains a medicine called atenolol. This belongs to a group of
medicines called
beta-blockers. It works by making your heart beat more slowly and with
less force.
/…/ is used to:
-
Treat high blood pressure (hypertension).
-
Treat certain types of uneven heart beats (arrhythmias).
-
Help prevent chest pain (angina).
-
Protect the heart in the early treatment after a heart attack
(myocardial infarction).
2.
WHAT YOU NEED TO KNOW BEFORE YOU USE /…/
DO NOT TAKE /…/
-
if you are allergic to atenolol or any of the other ingredients of
this medicine (listed in section
6).
-
if you have ever had or currently have any of the following heart
problems:
– heart failure which is not under control (this usually makes you
breathless and causes your
ankles to swell).
– second- or third-degree heart block (a condition which may be
treated by a pacemaker).
– collapse caused by severe heart problems (a condition called
cardiogenic shock where the
heart is unable to pump enough blood to the body).
– certain disorder in your heart rhythm

SPC

1
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Atenolol Actavis 25 mg film-coated tablets
Atenolol Actavis 50 mg film-coated tablets
Atenolol Actavis 100 mg film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each /…/ 25 mg film-coated tablet contains 25 mg atenolol
Each /…/ 50 mg film-coated tablet contains 50 mg atenolol
Each /…/ 100 mg film-coated tablet contains 100 mg atenolol
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet
/…/ 25 mg: White, round, biconvex film-coated tablet scored and with
AI engraved on one side.
/…/ 50 mg: White, round, biconvex film-coated tablet scored and with
AH engraved on one side.
/…/ 100 mg: White, round, biconvex film-coated tablet scored and
with AJ engraved on one side.
The tablet can be divided into equal doses.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
For the treatment of:
-
Hypertension
-
Chronic stable angina pectoris
-
Supraventricular arrhythmias:
- paroxysmal supraventricular tachycardia (in therapeutic or
prophylactic treatment)
- atrial fibrillation and atrial flutter: in case of inadequate
response to maximum dosages of
cardiac glycosides; in cases where cardiac glycosides may be
contraindicated or may be
associated with an unfavorable risk/benefit ratio
-
Ventricular arrhythmias:
- ventricular extrasystoles (prophylactic or therapeutic treatment),
if the extrasystoles are the
result of increased sympathetic activity
- ventricular tachycardias and ventricular fibrillation (prophylactic
treatment), especially when
the ventricular abnormality is the result of elevated sympathetic
activity
-
Secondary prevention after acute myocardial infarction
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
For oral administration.
Posology
The dosage should be determined on an individual basis. It is
recommended to start with the lowest
possible dosage so that heart failure, bradycardia and bronchial
symptoms are noticed timely. This is
especially important in elderly. Further adaptation